1. Home
  2. Stock quotes
  3. Stock Cue Biopharma
Cue Biopharma logo

Cue Biopharma CUE

$ 0.86 14.04%
mail-toReport an Error

Quarterly report 2025-Q2
added 08-12-2025

report update icon

Country

 usaUSA

IPO year

 2018

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITALSPB

Shares

 56.3 M

Market Cap[1]

 $ 48.4 M

EBITDA (LTM)

 $ -38.9 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Cellectis S.A. Cellectis S.A.
CLLS
 		$ 4.3 12.57 % $ 116 M Nasdaq Global Market franceFrance
Graybug Vision Graybug Vision
GRAY
 		$ 0.44 -11.23 % $ 9.65 M Nasdaq Global Market usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		$ 11.3 -10.17 % $ 12.2 K NYSE American -
Galera Therapeutics Galera Therapeutics
GRTX
 		$ 0.14 -32.59 % $ 7.61 M Nasdaq Global Market usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
 		$ 2.52 -1.18 % $ 6.35 M Nasdaq Global Select Market usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
 		$ 4.37 -1.58 % $ 28.1 M Nasdaq Global Market chinaChina
Caladrius Biosciences Caladrius Biosciences
CLBS
 		$ 0.43 -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		$ 184.71 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Midatech Pharma plc Midatech Pharma plc
MTP
 		$ 0.29 -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Aeterna Zentaris Aeterna Zentaris
AEZS
 		$ 5.72 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		$ 0.5 - $ 7.46 M Nasdaq Global Market israelIsrael
Generation Bio Co. Generation Bio Co.
GBIO
 		$ 6.33 1.61 % $ 408 M Nasdaq Global Select Market usaUSA
Kiromic BioPharma Kiromic BioPharma
KRBP
 		$ 3.15 6.61 % $ 3.08 M Nasdaq Global Select Market usaUSA
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		$ 179.68 - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		$ 44.15 -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		$ 0.32 - $ 23.9 M Nasdaq Global Select Market usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		$ 18.44 - $ 1.94 B Nasdaq Capital Market canadaCanada
Kaleido Biosciences Kaleido Biosciences
KLDO
 		$ 0.29 -3.69 % $ 12.4 M Nasdaq Global Select Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
 		$ 2.19 - $ 105 M Nasdaq Global Market usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
 		$ 1.35 2.27 % $ 206 M Nasdaq Global Select Market,SPB usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
 		$ 6.59 2.17 % $ 53.8 M Nasdaq Global Select Market usaUSA
Humanigen Humanigen
HGEN
 		$ 0.04 -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
 		$ 0.06 -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Tyme Technologies Tyme Technologies
TYME
 		$ 0.31 8.07 % $ 54 M Nasdaq Capital Market usaUSA
Keros Therapeutics Keros Therapeutics
KROS
 		$ 15.96 1.98 % $ 598 M Nasdaq Global Select Market usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
 		$ 2.64 -0.75 % $ 18.7 M Nasdaq Capital Market danmarkDanmark
Krystal Biotech Krystal Biotech
KRYS
 		$ 187.18 2.27 % $ 5.35 B Nasdaq Global Market,SPB usaUSA
Kymera Therapeutics Kymera Therapeutics
KYMR
 		$ 56.29 -1.11 % $ 4.22 B Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		$ 0.39 - $ 26.5 M Nasdaq Global Select Market usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		$ 0.47 - $ 12.5 M Nasdaq Global Market belgiumBelgium
Brickell Biotech Brickell Biotech
BBI
 		$ 2.11 -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		$ 0.05 -15.0 % $ 3.04 M Nasdaq Global Select Market usaUSA
Codiak BioSciences Codiak BioSciences
CDAK
 		$ 0.06 -55.98 % $ 2.15 M Nasdaq Global Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		$ 8.37 - $ 401 M Nasdaq Global Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		$ 3.17 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
 		$ 0.37 -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Forma Therapeutics Holdings Forma Therapeutics Holdings
FMTX
 		$ 20.01 - $ 958 M Nasdaq Global Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
 		$ 49.55 -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Sierra Oncology Sierra Oncology
SRRA
 		$ 54.89 -0.05 % $ 1.34 B Nasdaq Global Select Market canadaCanada

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.